{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:04:58Z","timestamp":1790049898597,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This work was supported by grants from the National Natural Science Foundation of China","award":["82272629"],"award-info":[{"award-number":["82272629"]}]},{"name":"Jiangsu Provincial Medical Key Discipline Cultivation Unit","award":["JSDW202239"],"award-info":[{"award-number":["JSDW202239"]}]},{"DOI":"10.13039\/501100019334","name":"Key Project of Science and Technology Development of Nanjing Medicine","doi-asserted-by":"publisher","award":["YKK24130"],"award-info":[{"award-number":["YKK24130"]}],"id":[{"id":"10.13039\/501100019334","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Industry-University-Research Innovation Fund for Chinese Universities -digital health project","award":["2023GY014"],"award-info":[{"award-number":["2023GY014"]}]},{"name":"Specialized Cohort Research Project of Nanjing Medical University","award":["NMUC2020035, NMUC2021013A"],"award-info":[{"award-number":["NMUC2020035, NMUC2021013A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10495-026-02306-1","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T07:11:50Z","timestamp":1772694710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["COL8A1-positive cancer-associated fibroblasts are drivers of 5-fluorouracil resistance in colorectal cancer"],"prefix":"10.1007","volume":"31","author":[{"given":"Muzi","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangshang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwei","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shukui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"issue":"1","key":"2306_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A (2025) Cancer statistics, 2025. CA A cancer. J Clin 75(1):10\u201345","journal-title":"J Clin"},{"key":"2306_CR2","unstructured":"Benson AB, Venook AP, Adam M, Chang G, Chen YJ, Ciombor KK et al (2024) Colon Cancer, version 3.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw JNCCN. 22(2 d)."},{"issue":"9","key":"2306_CR3","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1111\/cas.14532","volume":"111","author":"S Blondy","year":"2020","unstructured":"Blondy S, David V, Verdier M, Mathonnet M, Perraud A, Christou N (2020) 5-Fluorouracil resistance mechanisms in colorectal cancer: from classical pathways to promising processes. Cancer Sci 111(9):3142\u20133154","journal-title":"Cancer Sci"},{"key":"2306_CR4","doi-asserted-by":"crossref","unstructured":"Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P, Vymetalkova V (2020) 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future. Pharmacol Therapeut 206","DOI":"10.1016\/j.pharmthera.2019.107447"},{"issue":"4","key":"2306_CR5","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano L, Jord\u0101o MJC, Joyce JA (2021) Therapeutic targeting of the tumor microenvironment. Cancer Discov 11(4):933\u2013959","journal-title":"Cancer Discov"},{"issue":"3","key":"2306_CR6","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ccell.2023.02.015","volume":"41","author":"G Caligiuri","year":"2023","unstructured":"Caligiuri G, Tuveson DA (2023) Activated fibroblasts in cancer: perspectives and challenges. Cancer Cell 41(3):434\u2013449","journal-title":"Cancer Cell"},{"issue":"7","key":"2306_CR7","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1161\/CIRCRESAHA.123.324055","volume":"134","author":"Y Fu","year":"2024","unstructured":"Fu Y, Zhou Y, Wang K, Li Z, Kong W (2024) Extracellular matrix interactome in modulating vascular homeostasis and remodeling. Circul Res 134(7):931\u2013949","journal-title":"Circul Res"},{"issue":"9","key":"2306_CR8","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.trecan.2023.06.002","volume":"9","author":"H Su","year":"2023","unstructured":"Su H, Karin M (2023) Collagen architecture and signaling orchestrate cancer development. Trends Cancer 9(9):764\u2013773","journal-title":"Trends Cancer"},{"issue":"6","key":"2306_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s42255-022-00582-0","volume":"4","author":"EJ Kay","year":"2022","unstructured":"Kay EJ, Paterson K, Riera-Domingo C, Sumpton D, D\u00e4britz JHM, Tardito S et al (2022) Cancer-associated fibroblasts require proline synthesis by PYCR1 for the deposition of pro-tumorigenic extracellular matrix. Nat Metabol 4(6):693\u2013710","journal-title":"Nat Metabolism"},{"issue":"1","key":"2306_CR10","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1038\/s41467-022-32255-7","volume":"13","author":"M Papanicolaou","year":"2022","unstructured":"Papanicolaou M, Parker AL, Yam M, Filipe EC, Wu SZ, Chitty JL et al (2022) Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis. Nat Commun 13(1):4587","journal-title":"Nat Commun"},{"issue":"26","key":"2306_CR11","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1038\/s41388-021-01865-8","volume":"40","author":"YH Wu","year":"2021","unstructured":"Wu YH, Huang YF, Chang TH, Chen CC, Wu PY, Huang SC et al (2021) COL11A1 activates cancer-associated fibroblasts by modulating TGF-\u03b23 through the NF-\u03baB\/IGFBP2 axis in ovarian cancer cells. Oncogene 40(26):4503\u20134519","journal-title":"Oncogene"},{"issue":"12","key":"2306_CR12","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, McAndrews KM, Kalluri R (2021) Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol 18(12):792\u2013804","journal-title":"Nat Reviews Clin Oncol"},{"issue":"1","key":"2306_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41419-025-07461-y","volume":"16","author":"SG Dhamdhere","year":"2025","unstructured":"Dhamdhere SG, Bansal A, Singh P, Kakani P, Agrawal S, Samaiya A et al (2025) Hypoxia-induced ATF3 escalates breast cancer invasion by increasing collagen deposition via P4HA1. Cell Death Dis 16(1):142","journal-title":"Cell Death Dis"},{"issue":"19","key":"2306_CR14","first-page":"e2416523","volume":"12","author":"W Li","year":"2025","unstructured":"Li W, Wu Y, Zhang Y, Gao W, Li X, Luo H et al (2025) Halofuginone disrupted collagen deposition via mTOR-eIF2\u03b1-ATF4 axis to enhance chemosensitivity in ovarian cancer. Adv Sci (Weinheim Baden-Wurttemberg Germany) 12(19):e2416523","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"issue":"18","key":"2306_CR15","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1158\/0008-5472.CAN-23-3419","volume":"84","author":"C Bermejo-Rodriguez","year":"2024","unstructured":"Bermejo-Rodriguez C, Araos Henr\u00edquez J, Caligiuri G, Pinto Teles S, Park Y, Evans A et al (2024) Scribble deficiency promotes pancreatic ductal adenocarcinoma development and metastasis. Cancer Res 84(18):2968\u20132984","journal-title":"Cancer Res"},{"issue":"1","key":"2306_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13073-024-01367-8","volume":"16","author":"SY Jing","year":"2024","unstructured":"Jing SY, Liu D, Feng N, Dong H, Wang HQ, Yan X et al (2024) Spatial multiomics reveals a subpopulation of fibroblasts associated with cancer stemness in human hepatocellular carcinoma. Genome Med 16(1):98","journal-title":"Genome Med"},{"issue":"1","key":"2306_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41698-024-00762-z","volume":"8","author":"J Qian","year":"2024","unstructured":"Qian J, Xing H, Wang Y, Li C, Chen H, Rong J et al (2024) COL8A1 overexpression promotes glioma cell growth by activating focal adhesion kinase signaling cascade. NPJ Precision Oncol 8(1):273","journal-title":"NPJ Precision Oncol"},{"issue":"11","key":"2306_CR18","doi-asserted-by":"publisher","first-page":"e70621","DOI":"10.1111\/jcmm.70621","volume":"29","author":"C Xu","year":"2025","unstructured":"Xu C, He M, Chen H, Chi L, Wang X, Li S et al (2025) Evaluating the potential of COL8A1 as a therapeutic target for Chemoresistance, disease progression, and a prognostic marker in gastric cancer. J Cell Mol Med 29(11):e70621","journal-title":"J Cell Mol Med"},{"key":"2306_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.matbio.2022.11.002","volume":"114","author":"B Yan","year":"2022","unstructured":"Yan B, Liu L, Zhao L, Hinz U, Luo Y, An X et al (2022) Tumor and stroma COL8A1 secretion induces autocrine and paracrine progression signaling in pancreatic ductal adenocarcinoma. Matrix Biology: J Int Soc Matrix Biol 114:84\u2013107","journal-title":"Matrix Biology: J Int Soc Matrix Biology"},{"issue":"1","key":"2306_CR20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12943-024-02180-y","volume":"23","author":"X Zhou","year":"2024","unstructured":"Zhou X, Han J, Zuo A, Ba Y, Liu S, Xu H et al (2024) THBS2\u2009+\u2009cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K\/AKT activation in colorectal cancer. Mol Cancer 23(1):282","journal-title":"Mol Cancer"},{"issue":"9","key":"2306_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","volume":"18","author":"H Hamidi","year":"2018","unstructured":"Hamidi H, Ivaska J (2018) Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer 18(9):533\u2013548","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2306_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccell.2019.01.007","volume":"35","author":"J Cooper","year":"2019","unstructured":"Cooper J, Giancotti FG (2019) Integrin signaling in cancer: Mechanotransduction, Stemness, epithelial Plasticity, and therapeutic resistance. Cancer Cell 35(3):347\u2013367. https:\/\/doi.org\/10.1016\/j.ccell.2019.01.007","journal-title":"Cancer Cell"},{"issue":"1","key":"2306_CR23","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1186\/s12967-023-04696-1","volume":"21","author":"L Sun","year":"2023","unstructured":"Sun L, Guo S, Xie Y et al (2023) The characteristics and the multiple functions of integrin \u03b21 in human cancers. J Transl Med 21(1):787. https:\/\/doi.org\/10.1186\/s12967-023-04696-1[published Online First: 2023\/11\/07]","journal-title":"J Translational Med"},{"key":"2306_CR24","doi-asserted-by":"publisher","unstructured":"Guo J, Ma X, Liu D et al A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy 2024;76:101116. https:\/\/doi.org\/10.1016\/j.drup.2024.101116","DOI":"10.1016\/j.drup.2024.101116"},{"issue":"7","key":"2306_CR25","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/cac2.12460","volume":"43","author":"J Li","year":"2023","unstructured":"Li J, Xiao X, Ou Y et al (2023) USP51\/PD-L1\/ITGB1-deployed juxtacrine interaction plays a cell-intrinsic role in promoting chemoresistant phenotypes in non-small cell lung cancer. Cancer Commun (Lond Engl) 43(7):765\u2013787. https:\/\/doi.org\/10.1002\/cac2.12460","journal-title":"Cancer Commun (London England)"},{"key":"2306_CR26","doi-asserted-by":"publisher","first-page":"1185208","DOI":"10.3389\/fimmu.2023.1185208","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu X, Qin J, Nie J et al (2023) ANGPTL2\u2009+\u2009cancer-associated fibroblasts and SPP1\u2009+\u2009macrophages are metastasis accelerators of colorectal cancer. Front Immunol 14:1185208. https:\/\/doi.org\/10.3389\/fimmu.2023.1185208","journal-title":"Front Immunol"},{"issue":"10","key":"2306_CR27","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","volume":"23","author":"E Batlle","year":"2017","unstructured":"Batlle E, Clevers H (2017) Cancer stem cells revisited. Nat Med 23(10):1124\u20131134. https:\/\/doi.org\/10.1038\/nm.4409[published Online First: 2017\/10\/07]","journal-title":"Nat Med"},{"key":"2306_CR28","doi-asserted-by":"publisher","unstructured":"Nissen NI, Karsdal M, Willumsen N (2019) Collagens and cancer associated fibroblasts in the reactive stroma and its relation to cancer biology. J Exp Clin Cancer Res. https:\/\/doi.org\/10.1186\/s13046-019-1110-6","DOI":"10.1186\/s13046-019-1110-6"},{"key":"2306_CR29","doi-asserted-by":"publisher","unstructured":"Affo S, Nair A, Brundu F et al (2021) Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell. 39(6):866\u2009\u2013\u200982.e11. https:\/\/doi.org\/10.1016\/j.ccell.2021.03.012","DOI":"10.1016\/j.ccell.2021.03.012"},{"issue":"2","key":"2306_CR30","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1080\/15548627.2022.2093026","volume":"19","author":"J Bai","year":"2023","unstructured":"Bai J, Liu T, Tu B et al (2023) Autophagy loss impedes cancer-associated fibroblast activation via downregulating proline biosynthesis. Autophagy 19(2):632\u2013643. https:\/\/doi.org\/10.1080\/15548627.2022.2093026","journal-title":"Autophagy"},{"issue":"9","key":"2306_CR31","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1158\/0008-5472.Can-22-2034","volume":"83","author":"D De Martino","year":"2023","unstructured":"De Martino D, Bravo-Cordero JJ (2023) Collagens in cancer: structural regulators and guardians of cancer progression. Cancer Res 83(9):1386\u20131392. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-2034","journal-title":"Cancer Res"},{"issue":"6","key":"2306_CR32","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/ijc.34004","volume":"151","author":"J Zhang","year":"2022","unstructured":"Zhang J, Liu J, Zhang H et al (2022) The role of network-forming collagens in cancer progression. Int J Cancer 151(6):833\u2013842. https:\/\/doi.org\/10.1002\/ijc.34004","journal-title":"Int J Cancer"},{"issue":"1","key":"2306_CR33","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1186\/s12967-024-05759-7","volume":"22","author":"C Hou","year":"2024","unstructured":"Hou C, Huo J, Yan S et al (2024) Identification of fibrosis-associated biomarkers in heart failure and human cancers. J Transl Med 22(1):1042. https:\/\/doi.org\/10.1186\/s12967-024-05759-7","journal-title":"J Translational Med"},{"key":"2306_CR34","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12935-020-01465-8","volume":"20","author":"W Peng","year":"2020","unstructured":"Peng W, Li JD, Zeng JJ et al (2020) Clinical value and potential mechanisms of COL8A1 upregulation in breast cancer: a comprehensive analysis. Cancer Cell Int 20:392. https:\/\/doi.org\/10.1186\/s12935-020-01465-8","journal-title":"Cancer Cell Int"},{"issue":"3","key":"2306_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jnc.16049","volume":"168","author":"S Fan","year":"2024","unstructured":"Fan S, Li H, Liu K (2024) Molecular prognostic of nine parthanatos death-related genes in glioma, particularly in COL8A1 identification. J Neurochem 168(3):205\u2013223. https:\/\/doi.org\/10.1111\/jnc.16049","journal-title":"J Neurochem"},{"key":"2306_CR36","doi-asserted-by":"crossref","unstructured":"Slack RJ, Macdonald SJF, Roper JA, Debaugnies M, Rodr\u00edguez-Acebes S, Blondeau J, Parent MA, Zocco M, Song Y et al (2022) Emerging therapeutic opportunities for integrin inhibitors. Nature reviews Drug discovery. RHOJ controls EMT-associated resistance to chemotherapy. Nature. 2023;616(7955):168\u2009\u2013\u200975","DOI":"10.1038\/s41586-023-05838-7"},{"issue":"1","key":"2306_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-018-0694-6","volume":"37","author":"J Luo","year":"2018","unstructured":"Luo J, Yao JF, Deng XF, Zheng XD, Jia M, Wang YQ et al (2018) 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin \u03b1v\u03b23 and activating FAK\/PI3K\/AKT signaling. J Exp Clin Cancer Res CR 37(1):23","journal-title":"J Experimental Clin Cancer Research: CR"},{"issue":"3","key":"2306_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/cac2.12138","volume":"41","author":"G Pan","year":"2021","unstructured":"Pan G, Liu Y, Shang L, Zhou F, Yang S (2021) EMT-associated MicroRNAs and their roles in cancer stemness and drug resistance. Cancer Commun (Lond Engl) 41(3):199\u2013217","journal-title":"Cancer Commun (London England)"},{"issue":"10","key":"2306_CR39","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue T, Weinberg RA (2017) EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol 14(10):611\u2013629","journal-title":"Nat Reviews Clin Oncol"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02306-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02306-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02306-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:26:01Z","timestamp":1774985161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02306-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2306"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02306-1","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have provided their consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that no conflict of interest exists.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Committees and Institutional Review Boards of Nanjing First Hospital, affiliated with Nanjing Medical University (Approval No. KY20220124-04). The patients\/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"All animal experimental procedures were reviewed and approved by the Animal Ethics Committee of Nanjing Hospital Affiliated to Nanjing Medical University (Protocol No. DWSY-2409551) and were performed in accordance with relevant institutional guidelines.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal ethics"}}],"article-number":"85"}}